Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients. (Q43253108)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Evelyne Jacqz-Aigrain

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Wei Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

V Elie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

G Roussey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

K Brochard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

P Niaudet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

V Leroy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

C Loirat

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

P Cochat

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

S Cloarec

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

J L André

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

F Garaix

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Bensman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

M Fakhoury

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

28 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

609-618

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865079%20AND%20SRC:MED&resulttype=core&format=json

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Increased tacrolimus trough levels in association with severe diarrhea, a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Population pharmacokinetics of tacrolimus in adult kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Mechanism-based concepts of size and maturity in pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

A general model for the origin of allometric scaling laws in biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Population clinical pharmacology of children: modelling covariate effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Standard dosing of tacrolimus leads to overexposure in pediatric renal transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Therapeutic drug monitoring of mycophenolate mofetil in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Stability and performance of a population pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Extensions to the visual predictive check to facilitate model performance evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

7 January 2021

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

7 January 2021

CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

7 January 2021

The pharmacokinetics and immunosuppressive response of tacrolimus in paediatric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

7 January 2021

CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

7 January 2021

Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.210

7 January 2021